New personalized therapy boosts tamoxifen effectiveness in breast cancer patients

[News]

Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has now developed a new therapy in a clinical study that tailors hormone treatment for breast cancer to the individual patient.

More... (https://www.news-medical.net/news/20251016/New-personalized-therapy-boosts-tamoxifen-effectiveness-in-breast-cancer-patients.aspx)